Dalrada Health Appoints Aboo Nasar, M.D. as Sòlas Rejuvenation and Wellness’ Medical Director
Dalrada Corporation (OTCQB: DFCO) has appointed Dr. Aboo Nasar as the new Medical Director for its subsidiary, Dalrada Health's Sòlas Rejuvenation + Wellness center in San Diego. With over 22 years of experience, Dr. Nasar is board-certified in Holistic and Anti-Aging Functional Regenerative Medicine. He has founded three successful medical spas and aims to enhance personalized healthcare services. The North American precision medicine market is growing rapidly, set to exceed USD 23.2 billion by 2027, providing a promising backdrop for Sòlas' innovative health services.
- Appointment of Dr. Aboo Nasar as Medical Director enhances leadership and expertise.
- Dr. Nasar's extensive experience in regenerative medicine could improve patient outcomes.
- Growth in the North American precision medicine market presents opportunities for Sòlas' services.
- Concerns about continuity and experience gaps as new leadership takes charge.
Sòlas’ flagship health and wellness center in
The Sòlas facility features private, tailored, state-of-the-art services where its guests can select from a wide range of therapies that currently include:
- Aesthetics
- Regenerative Therapy
- Healthy Habits
-
IV Therapy Lounge - Hormone Rebalancing
- Men's Health & Wellness
-
Women's Health & Wellness - Customized Services
- Wellness Products
A precision medicine market report reveals that ailments of the central nervous system (CNS) catalyzed growth in
Overall, the North America Precision Medicine Market size surpassed
Precision health and wellness contrasts a one-size-fits-all approach, lending more significant consideration to an individual's genetic factors. These unique factors align with precision therapies and targeted treatments at Sòlas, optimizing care in the region.
- Hospital Boards
- Accountable Care Organizations (ACO)
- Medical Director of Skilled Nursing Facilities (SNFs) & Hospice Palliative Care Services
- Overseeing Senior Medical Associates 100+ Healthcare Providers
- National and international public speaker - Integrative and Functional Regenerative Medicine
Additional specialties of
Sòlas Rejuvenation + Wellness takes a dedicated approach to prioritizing health and providing individualized, quality client service. For additional details on advanced rejuvenation techniques and specialized wellness programs, visit www.solasrejuvenation.com.
Continuously building on its core life sciences, technology, and engineering practices, Dalrada operates under the tenet of bringing innovative products and services to a complex new world. As consumers, businesses, and governments seek alternative solutions, Dalrada's subsidiaries respond with affordable, available, accessible, and impactful innovations. Visit www.dalrada.com and www.dalradahealth.com for more information.
About
A wholly-owned subsidiary of
About Dalrada (DFCO)
With perseverance, valor, dedication, and vision,
Dalrada is a global company that operates under the tenet of creating impactful innovations that matter for the world. The Company works continually to produce disruptive solutions that bridge the gap of accessibility and accelerate positive change for current and future generations.
Established in 1982, the Company has since grown its footprint to include the business divisions:
Disclaimer
Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20220210005389/en/
858.283.1253
inquiries@dalrada.com
Source:
FAQ
Who is the new Medical Director at Dalrada Health?
What experience does Dr. Aboo Nasar bring to Dalrada Health?
How might Dr. Nasar's appointment impact Dalrada Corporation (DFCO)?